TRAVERE THERAPEUTICS, INC. Pre-Tax Income
TRAVERE THERAPEUTICS, INC. (TVTX) reported Pre-Tax Income of -$35.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2026-08-04
- TRAVERE THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-06-30 was -$35.00M.
- TRAVERE THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-03-31 was -$36.72M.
- TRAVERE THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-12-31 was -$21.07M.
- TRAVERE THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-09-30 was $25.71M.
- TRAVERE THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2025 was -$49.27M.
- TRAVERE THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2024 was -$320.51M.
- TRAVERE THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2023 was -$376.11M.
- TRAVERE THERAPEUTICS, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2022 was -$331.15M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month as first filed | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 34 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 34 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$35.00M 10-Q · filed 2026-08-04 | -$71.72M 10-Q · filed 2026-08-04 | -$92.79M derived: sum of 3 quarters · filed 2026-08-04 | -$67.07M derived: sum of 4 quarters · filed 2026-08-04 | ||||||
| 2026-03-31 | -$36.72M 10-Q · filed 2026-05-04 | -$57.79M derived: sum of 2 quarters · filed 2026-05-04 | -$32.07M derived: sum of 3 quarters · filed 2026-05-04 | -$44.81M derived: sum of 4 quarters · filed 2026-08-04 | ||||||
| 2025-12-31 | -$21.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $4.65M derived: sum of 2 quarters · filed 2026-02-19 | -$8.09M derived: sum of 3 quarters · filed 2026-08-04 | -$49.27M 10-K · filed 2026-02-19 | ||||||
| 2025-09-30 | $25.71M 10-Q · filed 2025-10-30 | $12.98M derived: sum of 2 quarters · filed 2026-08-04 | -$28.21M 10-Q · filed 2025-10-30 | -$88.55M derived: sum of 4 quarters · filed 2026-08-04 | ||||||
| 2025-06-30 | -$12.73M 10-Q · filed 2026-08-04 | -$53.92M 10-Q · filed 2026-08-04 | -$114.26M derived: sum of 3 quarters · filed 2026-08-04 | -$169.10M derived: sum of 4 quarters · filed 2026-08-04 | ||||||
| 2025-03-31 | -$41.19M 10-Q · filed 2026-05-04 | -$101.53M derived: sum of 2 quarters · filed 2026-05-04 | -$156.36M derived: sum of 3 quarters · filed 2026-05-04 | -$225.93M derived: sum of 4 quarters · filed 2026-05-04 | ||||||
| 2024-12-31 | -$60.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$115.18M derived: sum of 2 quarters · filed 2026-02-19 | -$184.74M derived: sum of 3 quarters · filed 2026-02-19 | -$320.51M 10-K · filed 2026-02-19 | ||||||
| 2024-09-30 | -$54.84M 10-Q · filed 2025-10-30 | -$124.40M derived: sum of 2 quarters · filed 2025-10-30 | -$260.17M 10-Q · filed 2025-10-30 | -$348.70M derived: sum of 4 quarters · filed 2025-10-30 | ||||||
| 2024-06-30 | -$69.57M 10-Q · filed 2025-08-06 | -$205.33M 10-Q · filed 2025-08-06 | -$293.86M derived: sum of 3 quarters · filed 2025-08-06 | -$383.09M derived: sum of 4 quarters · filed 2025-08-06 | ||||||
| 2024-03-31 | -$135.77M 10-Q · filed 2025-05-01 | -$224.29M derived: sum of 2 quarters · filed 2025-05-01 | -$313.52M derived: sum of 3 quarters · filed 2025-05-01 | -$415.39M derived: sum of 4 quarters · filed 2025-05-01 | ||||||
| 2023-12-31 | -$88.53M 10-K · filed 2024-02-20 | -$177.76M derived: sum of 2 quarters · filed 2024-10-31 | -$279.62M derived: sum of 3 quarters · filed 2024-10-31 | -$376.11M 10-K · filed 2026-02-19 | ||||||
| 2023-09-30 | -$89.23M 10-Q · filed 2024-10-31 | -$191.10M derived: sum of 2 quarters · filed 2024-10-31 | -$287.58M 10-Q · filed 2024-10-31 | -$373.15M derived: sum of 4 quarters · filed 2024-10-31 | ||||||
| 2023-06-30 | -$101.87M 10-Q · filed 2024-08-01 | -$85.56M 10-Q · filed 2023-08-03 | -$198.35M 10-Q · filed 2024-08-01 | -$171.82M 10-Q · filed 2023-08-03 | -$283.93M derived: sum of 3 quarters · filed 2024-08-01 | -$367.84M derived: sum of 4 quarters · filed 2024-08-01 | ||||
| 2023-03-31 | -$96.49M 10-Q · filed 2024-05-06 | -$86.25M 10-Q · filed 2023-05-04 | -$182.06M derived: sum of 2 quarters · filed 2024-05-06 | -$265.98M derived: sum of 3 quarters · filed 2024-05-06 | -$345.95M derived: sum of 4 quarters · filed 2024-05-06 | |||||
| 2022-12-31 | -$85.57M 10-K · filed 2024-02-20 | -$169.49M derived: sum of 2 quarters · filed 2024-02-20 | -$249.46M derived: sum of 3 quarters · filed 2024-02-20 | -$331.15M 10-K · filed 2025-02-21 | -$278.17M 10-K · filed 2023-02-23 | |||||
| 2022-09-30 | -$83.92M 10-K · filed 2024-02-20 | -$69.51M 10-Q · filed 2022-10-27 | -$163.89M derived: sum of 2 quarters · filed 2024-02-20 | -$245.58M 10-Q · filed 2023-11-07 | -$212.41M 10-Q · filed 2022-10-27 | -$334.35M derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-06-30 | -$79.97M 10-K · filed 2024-02-20 | -$66.98M 10-Q · filed 2022-08-04 | -$142.90M 10-Q · filed 2023-08-03 | -$250.43M derived: sum of 3 quarters · filed 2024-02-20 | -$286.03M derived: sum of 4 quarters · filed 2024-02-20 | |||||
| 2022-03-31 | -$81.69M 10-K · filed 2024-02-20 | -$75.92M 10-Q · filed 2022-05-05 | -$170.46M derived: sum of 2 quarters · filed 2024-02-20 | -$206.06M derived: sum of 3 quarters · filed 2024-02-20 | -$245.02M derived: sum of 4 quarters · filed 2024-02-20 | |||||
| 2021-12-31 | -$88.77M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | -$124.37M derived: sum of 2 quarters · filed 2024-02-20 | -$163.33M derived: sum of 3 quarters · filed 2024-02-20 | -$216.88M 10-K · filed 2024-02-20 | -$179.68M 10-K · filed 2022-02-24 | |||||
| 2021-09-30 | -$35.60M 10-Q · filed 2022-10-27 | -$74.56M derived: sum of 2 quarters · filed 2022-10-27 | -$128.11M 10-Q · filed 2022-10-27 | -$250.21M derived: sum of 4 quarters · filed 2022-10-27 | ||||||
| 2021-06-30 | -$38.96M 10-Q · filed 2022-08-04 | -$92.52M 10-Q · filed 2022-08-04 | -$214.61M derived: sum of 3 quarters · filed 2022-08-04 | -$237.14M derived: sum of 4 quarters · filed 2022-08-04 | ||||||
| 2021-03-31 | -$53.55M 10-Q · filed 2022-05-05 | -$175.65M derived: sum of 2 quarters · filed 2022-05-05 | -$198.17M derived: sum of 3 quarters · filed 2022-05-05 | -$224.18M derived: sum of 4 quarters · filed 2022-05-05 | ||||||
| 2020-12-31 | -$122.09M 10-K · filed 2021-03-01 | -$144.62M derived: sum of 2 quarters · filed 2021-10-29 | -$170.62M derived: sum of 3 quarters · filed 2021-10-29 | -$188.79M 10-K · filed 2023-02-23 | ||||||
| 2020-09-30 | -$22.53M 10-Q · filed 2021-10-29 | -$48.53M derived: sum of 2 quarters · filed 2021-10-29 | -$66.70M 10-Q · filed 2021-10-29 | -$96.92M derived: sum of 4 quarters · filed 2021-10-29 | ||||||
| 2020-06-30 | -$26.00M 10-Q · filed 2021-07-29 | -$44.17M 10-Q · filed 2021-07-29 | -$74.40M derived: sum of 3 quarters · filed 2021-07-29 | -$111.41M derived: sum of 4 quarters · filed 2021-07-29 | ||||||
| 2020-03-31 | -$18.17M 10-Q · filed 2021-05-06 | -$48.40M derived: sum of 2 quarters · filed 2021-05-06 | -$85.41M derived: sum of 3 quarters · filed 2021-05-06 | -$124.04M derived: sum of 4 quarters · filed 2021-05-06 | ||||||
| 2019-12-31 | -$30.23M 10-K · filed 2021-03-01 | -$67.24M derived: sum of 2 quarters · filed 2021-03-01 | -$105.87M derived: sum of 3 quarters · filed 2021-03-01 | -$146.45M 10-K · filed 2022-02-24 | ||||||
| 2019-09-30 | -$37.01M 10-K · filed 2021-03-01 | -$75.64M derived: sum of 2 quarters · filed 2021-03-01 | -$116.22M 10-Q · filed 2020-11-05 | -$123.68M derived: sum of 4 quarters · filed 2021-03-01 | ||||||
| 2019-06-30 | -$38.63M 10-K · filed 2021-03-01 | -$79.21M 10-Q · filed 2020-07-31 | -$86.66M derived: sum of 3 quarters · filed 2021-03-01 | -$140.76M derived: sum of 4 quarters · filed 2021-03-01 | ||||||
| 2019-03-31 | -$40.58M 10-K · filed 2021-03-01 | -$48.03M derived: sum of 2 quarters · filed 2021-03-01 | -$102.13M derived: sum of 3 quarters · filed 2021-03-01 | -$124.29M derived: sum of 4 quarters · filed 2021-03-01 | ||||||
| 2018-12-31 | -$7.46M 10-K · filed 2020-02-24 | -$61.56M derived: sum of 2 quarters · filed 2020-02-24 | -$83.72M derived: sum of 3 quarters · filed 2020-02-24 | -$101.87M 10-K · filed 2021-03-01 | ||||||
| 2018-09-30 | -$54.10M 10-K · filed 2020-02-24 | -$76.26M derived: sum of 2 quarters · filed 2020-02-24 | -$94.41M 10-Q · filed 2019-10-30 | -$105.45M derived: sum of 4 quarters · filed 2020-02-24 | ||||||
| 2018-06-30 | -$22.16M 10-K · filed 2020-02-24 | -$40.31M 10-Q · filed 2019-08-06 | -$51.35M derived: sum of 3 quarters · filed 2020-02-24 | -$70.37M derived: sum of 4 quarters · filed 2020-02-24 | ||||||
| 2018-03-31 | -$18.15M 10-K · filed 2020-02-24 | -$29.19M derived: sum of 2 quarters · filed 2020-02-24 | -$48.20M derived: sum of 3 quarters · filed 2020-02-24 | -$63.36M derived: sum of 4 quarters · filed 2020-02-24 | ||||||
| 2017-12-31 | -$11.04M 10-K · filed 2019-02-26 | -$11.00K 10-K · filed 2018-02-27 | -$30.05M derived: sum of 2 quarters · filed 2019-02-26 | -$45.21M derived: sum of 3 quarters · filed 2019-02-26 | -$58.36M 10-K · filed 2020-02-24 | |||||
| 2017-09-30 | -$19.02M 10-K · filed 2019-02-26 | -$34.17M derived: sum of 2 quarters · filed 2019-02-26 | -$47.33M 10-Q · filed 2018-11-01 | -$59.61M derived: sum of 4 quarters · filed 2019-02-26 | ||||||
| 2017-06-30 | -$15.15M 10-K · filed 2019-02-26 | -$28.31M 10-Q · filed 2018-08-03 | -$40.59M derived: sum of 3 quarters · filed 2019-02-26 | -$71.24M derived: sum of 4 quarters · filed 2019-02-26 | ||||||
| 2017-03-31 | -$13.15M 10-K · filed 2019-02-26 | -$25.44M derived: sum of 2 quarters · filed 2019-02-26 | -$56.09M derived: sum of 3 quarters · filed 2019-02-26 | -$76.88M derived: sum of 4 quarters · filed 2019-02-26 | ||||||
| 2016-12-31 | -$12.29M 10-K · filed 2018-07-06 | -$42.93M derived: sum of 2 quarters · filed 2018-07-06 | -$63.73M derived: sum of 3 quarters · filed 2018-07-06 | -$57.58M 10-K · filed 2019-02-26 | ||||||
| 2016-09-30 | -$30.65M 10-K · filed 2018-07-06 | -$51.44M derived: sum of 2 quarters · filed 2018-07-06 | -$45.29M 10-Q · filed 2017-11-07 | -$58.29M derived: sum of 4 quarters · filed 2018-07-06 | ||||||
| 2016-06-30 | -$20.80M 10-K · filed 2018-07-06 | -$14.65M 10-Q · filed 2017-08-09 | -$27.64M derived: sum of 3 quarters · filed 2018-07-06 | $116.70M derived: sum of 4 quarters · filed 2018-07-06 | ||||||
| 2016-03-31 | $6.15M 10-K · filed 2018-07-06 | -$6.85M derived: sum of 2 quarters · filed 2018-07-06 | $137.49M derived: sum of 3 quarters · filed 2018-07-06 | $111.98M derived: sum of 4 quarters · filed 2018-07-06 | ||||||
| 2015-12-31 | -$12.99M 10-K · filed 2017-03-01 | $131.34M derived: sum of 2 quarters · filed 2017-03-01 | $105.83M derived: sum of 3 quarters · filed 2017-03-01 | $105.47M 10-K · filed 2018-07-06 | ||||||
| 2015-09-30 | $144.34M 10-K · filed 2017-03-01 | $118.83M derived: sum of 2 quarters · filed 2017-03-01 | $118.46M 10-Q · filed 2016-11-04 | $89.43M derived: sum of 4 quarters · filed 2017-03-01 | ||||||
| 2015-06-30 | -$25.51M 10-K · filed 2017-03-01 | -$25.88M 10-Q · filed 2016-08-05 | -$54.91M derived: sum of 3 quarters · filed 2017-03-01 | -$72.89M derived: sum of 4 quarters · filed 2017-03-01 | ||||||
| 2015-03-31 | -$366.00K 10-K · filed 2017-03-01 | -$366.16K 10-Q · filed 2015-05-11 | -$29.39M derived: sum of 2 quarters · filed 2017-03-01 | -$47.37M derived: sum of 3 quarters · filed 2017-03-01 | -$38.09M derived: sum of 4 quarters · filed 2017-03-01 | |||||
| 2014-12-31 | -$29.03M 10-K · filed 2015-03-11 | -$47.01M derived: sum of 2 quarters · filed 2016-02-26 | -$37.73M derived: sum of 3 quarters · filed 2016-02-26 | -$113.40M 10-K · filed 2017-03-01 | -$113.40M 10-K · filed 2015-03-11 | |||||
| 2014-09-30 | -$17.98M 10-K · filed 2016-02-26 | -$19.56M 10-Q · filed 2014-11-13 | -$8.70M derived: sum of 2 quarters · filed 2016-02-26 | -$84.37M 10-Q · filed 2015-11-06 | -$84.16M 10-Q · filed 2014-11-13 | -$97.12M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | $9.28M 10-K · filed 2016-02-26 | $5.96M 10-Q · filed 2014-08-14 | -$66.39M 10-Q · filed 2015-08-10 | -$64.60M 10-Q · filed 2014-08-14 | -$79.14M derived: sum of 3 quarters · filed 2016-02-26 | -$91.15M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | -$75.67M 10-K · filed 2016-02-26 | -$70.56M 10-Q · filed 2014-05-15 | -$88.42M derived: sum of 2 quarters · filed 2016-02-26 | -$100.43M derived: sum of 3 quarters · filed 2016-02-26 | -$105.35M derived: sum of 4 quarters · filed 2016-02-26 | |||||
| 2013-12-31 | -$12.75M 10-K · filed 2015-03-11 | -$24.76M derived: sum of 2 quarters · filed 2015-03-11 | -$29.68M derived: sum of 3 quarters · filed 2015-03-11 | -$34.55M 10-K · filed 2016-02-26 | -$33.75M 10-K · filed 2014-03-28 | -$68.16M 10-K/A · filed 2015-07-09 | -$67.36M 10-K · filed 2014-03-28 | |||
| 2013-09-30 | -$12.01M 10-K · filed 2015-03-11 | -$10.90M 10-Q · filed 2014-11-13 | -$16.93M derived: sum of 2 quarters · filed 2015-03-11 | -$20.69M 10-Q · filed 2014-11-13 | ||||||
| 2013-06-30 | -$4.92M 10-K · filed 2015-03-11 | -$5.05M 10-Q · filed 2014-08-14 | -$9.79M 10-Q · filed 2014-08-14 | |||||||
| 2013-03-31 | -$4.87M 10-K · filed 2015-03-11 | -$4.87M 10-Q · filed 2014-05-15 | ||||||||
| 2012-12-31 | -$30.34M 10-K/A · filed 2015-07-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |